GE HealthCare Technologies Inc. filings document formal disclosures for a medical technology and diagnostics company, including Form 8-K reports on results of operations and financial condition, material agreements, capital-structure matters, and governance changes. Recent current reports include earnings releases, a senior unsecured revolving credit facility, and board-related disclosures.
The company’s proxy materials describe annual-meeting matters, director elections, board committee assignments, executive compensation, equity awards, and shareholder voting procedures. GEHC filings also provide formal context for segment performance, liquidity arrangements, credit covenants, and governance matters tied to its healthcare technology, software, and pharmaceutical diagnostics businesses.
GE HealthCare Technologies Inc. (GEHC) reported that President and CEO Peter J. Arduini had 6,303 shares of common stock withheld on September 3, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. After this withholding, he directly holds 241,606 shares of GEHC common stock.
GE HealthCare Technologies Inc. (GEHC) disclosed that Philip Rackliffe, CEO, AIS, reported three dispositions of common stock on September 1, 2026. A total of 856 shares of common stock were withheld at $71.23 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units. These are reported as payments of tax liability by delivering or withholding securities, not as open‑market sales, and no Rule 10b5-1 trading plan is indicated.
GE HealthCare Technologies Inc. (GEHC) reported that Chief Technology Officer Taha Kass-Hout had shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units.
Two code F transactions were reported, covering 1,644 and 1,296 shares at $71.23 per share, for a total of 2,940 shares delivered or withheld for payment of tax liability. No Rule 10b5-1 trading plan is indicated for these transactions.
GE HealthCare Technologies Inc. (GEHC) reported that officer Frank R. Jimenez, GC & Corporate Secretary, had 3,131 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. These dispositions were not reported as being made under a Rule 10b5-1 trading plan.
GE HealthCare Technologies Inc. (GEHC) reported that Chief People Officer Adam Y. Holton had 659 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units. The shares were valued at $71.23 per share for this tax-withholding transaction, which is reported as a disposition but not an open-market sale. After this event, Holton directly held 20,206 shares of GE HealthCare common stock. No transactions are reported as made under a Rule 10b5-1 trading plan.
GE HealthCare Technologies Inc. (GEHC) reported that Jeannette Bankes, CEO, Patient Care Solutions, had 1,064 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units. After this tax-withholding disposition, she holds 37,293 shares of GE HealthCare common stock directly, and no Rule 10b5-1 plan is reported.
GE HealthCare Technologies Inc. (GEHC) reported that President and CEO Peter J. Arduini had 11,515 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units. These are code F transactions and not open-market purchases or sales.
GE HealthCare Technologies Inc. (GEHC) reported that Chief People Officer Adam Y. Holton had 1,360 shares of common stock withheld on 2026-08-15 to satisfy tax withholding obligations in connection with the vesting of restricted stock units. After this tax-related share withholding, he directly holds 20,865 shares of GEHC common stock.
GE HealthCare Technologies Inc. appointed William (Bill) Grogan as Chief Financial Officer, effective September 14, 2026, succeeding the previously announced departure of Jay Saccaro. Interim CFO George Newcomb will cease serving in that interim role on that date and continue as Controller and Chief Accounting Officer.
Grogan joins from Xylem Inc., a global water solutions company with approximately $9 billion in revenue, where he has served as executive vice president and CFO since 2023 and helped integrate a $7.5 billion acquisition. His compensation package includes a $900,000 base salary, target annual bonus equal to 100% of base salary, annual LTI with a target grant date value of $3,300,000, a $550,000 cash sign-on payment, and a one-time sign-on RSU award with a grant date value of $4,000,000, plus an additional 2026 annual LTI award of $3,300,000.
The company describes itself as a leading global healthcare solutions provider with $20.6 billion in business and approximately 54,000 colleagues, focused on advanced medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions.
Dodge & Cox filed an amended Schedule 13G reporting beneficial ownership of 47,334,058 shares of GE HealthCare Technologies Inc. common stock, representing 10.5% of the class. Dodge & Cox has sole voting power over 44,872,703 shares and sole dispositive power over all 47,334,058 shares, with no shared voting or dispositive power.
The filing states that clients of Dodge & Cox have the right to receive or direct dividends and sale proceeds for these shares. Dodge & Cox Stock Fund, a registered investment company, holds an interest in 30,726,266 shares, equal to 6.8% of the common stock class reported.